Zai Lab Ltd financial data

Symbol
ZLAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4560 Jinke Road, Bldg. 1, 4 F, Pudong, Shanghai, China
Fiscal year end
December 31
Latest financial report
May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 330 % -43.3%
Quick Ratio 15.1 % -39.7%
Debt-to-equity 43.3 % +81.6%
Return On Equity -33.4 % +17.1%
Return On Assets -23.3 % +28.3%
Operating Margin -64.1 % +49.2%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 1.08B shares +11.4%
Entity Public Float 1.7B USD -37%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 1.08B shares +11.1%
Weighted Average Number of Shares Outstanding, Diluted 1.08B shares +11.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 418M USD +43.7%
Revenue from Contract with Customer, Excluding Assessed Tax 416M USD +43%
Cost of Revenue 108M USD +35.6%
Research and Development Expense 241M USD -11.6%
Operating Income (Loss) -268M USD +27%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -252M USD +25.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -252M USD +25.6%
Earnings Per Share, Basic -0.25 USD/shares +28.6%
Earnings Per Share, Diluted -0.25 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 757M USD +16.4%
Accounts Receivable, after Allowance for Credit Loss, Current 76.6M USD +26.7%
Inventory, Net 53.1M USD +40.2%
Assets, Current 1.04B USD +17.2%
Property, Plant and Equipment, Net 49.7M USD -5.22%
Operating Lease, Right-of-Use Asset 19.1M USD +25.6%
Intangible Assets, Net (Excluding Goodwill) 56.2M USD +353%
Other Assets, Noncurrent 2.53M USD
Assets 1.17B USD +18.7%
Accounts Payable, Current 103M USD +16.9%
Employee-related Liabilities, Current 12.2M USD +2.08%
Liabilities, Current 320M USD +66.5%
Operating Lease, Liability, Noncurrent 12.3M USD +63.4%
Other Liabilities, Noncurrent 325K USD 0%
Liabilities 363M USD +60.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 49.3M USD +25.9%
Retained Earnings (Accumulated Deficit) -2.5B USD -11.2%
Stockholders' Equity Attributable to Parent 811M USD +6.37%
Liabilities and Equity 1.17B USD +18.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -61.7M USD +31.5%
Net Cash Provided by (Used in) Financing Activities 43.1M USD -9.27%
Net Cash Provided by (Used in) Investing Activities 326M USD +9807%
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 1.09B shares +11.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 308M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.1M USD +2347%
Deferred Tax Assets, Valuation Allowance 395M USD +10.3%
Operating Lease, Liability 21.8M USD +43.6%
Depreciation 8.4M USD +3.7%
Payments to Acquire Property, Plant, and Equipment 1.53M USD +57.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -242M USD +23.7%
Lessee, Operating Lease, Liability, to be Paid 23.2M USD +48.4%
Property, Plant and Equipment, Gross 88.7M USD +4.84%
Operating Lease, Liability, Current 6.57M USD -12.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.99M USD -2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.61M USD +15.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.4M USD +204%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.73M USD +106%
Deferred Tax Assets, Operating Loss Carryforwards 321M USD +8.72%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.91M USD +254%
Amortization of Intangible Assets 1.5M USD +114%
Depreciation, Depletion and Amortization 3.46M USD +14.8%
Deferred Tax Assets, Net of Valuation Allowance 3.77M USD +33.3%
Share-based Payment Arrangement, Expense 68.5M USD -15.4%
Interest Expense 113K USD